Mission-Driven Leadership, With Global Experience in Innovative Therapies

Meet the Apobiologix Leadership Team.

Apobiologix is a division of ApoPharma USA, Inc, which is a member of the Apotex Group of Companies. Apotex is the largest privately-owned Canadian pharmaceutical company.

Our senior leadership brings decades of experience in research, development, and marketing of innovative pharmaceutical solutions.

Dr. Klaus Martin
Dr. Klaus Martin
President, Apobiologix

With Apotex since 2018

16 years' experience in pharmaceuticals

Previously with Polpharma Biologics, Sandoz

MSc in Biochemistry, PhD in Molecular Genetics

Mike Woolcock
Mike Woolcock
Senior VP, Commercial Operations

With Apotex since 2012

32 years' experience in pharmaceuticals

Previously with Amgen and P&G

BS Biochemistry & Genetics

Omar Jabri
Omar Jabri
Director, GIP and Lead Attorney

With Apotex since 2011

10 years' of legal experience

Previously with Frommer Lawrence & Haug LLP (NYC), Wilson Sonsini PC (NYC)

Hon. BSc (Neuroscience), JD, LLM

Mike Woolcock
Michael Ascenzo
Global Director, Business Development

With Apotex since 2003

13 years' experience in pharmaceuticals

BA Economics
MBA Marketing & Strategic Management

Dr. Jason Dowd
Dr. Jason Dowd
Director, Product Development, Biopharmaceuticals

With Apotex since 2009

14 years' experience in pharmaceuticals

Previously with Bayer, INEX, and StemCell Technologies

PhD in Chemical and Biological Engineering

Nirmesh Shah
Dr. Nirmesh Shah
Director, Medical Affairs

With Apotex since 2015

13 years' experience in pharmaceuticals

Previously with Quintiles Transnational, Johnson & Johnson, and Sunovion


Invention is not the only innovation.

Apobiologix logo

2400 North Commerce Parkway,
Suite 300,
Weston, Florida 33326